Abstract 2635: Novel tumor microenvironment (TME) activated interleukin-2 (IL-2) fused to anti-PD-1 or anti-PD-1/VEGF-A antibodies for enhanced anti-tumor immunity.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Rui Zhang, Cheng Liu, Yuan Liu
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148837806
Cites:
Cited by:
Related to: